Public register entity · France
BIOGEN TECHNOLOGIES EUROPE SASU
898128525.FR
- Basis
- solo
Financial data filed with a public register. Not a listed company and not a tradable security — this page carries no price and no forecast.
Public register entity · France
898128525.FR
Financial data filed with a public register. Not a listed company and not a tradable security — this page carries no price and no forecast.
As first reported — the figures as originally filed, not later restatements.
Latest filing: FY2025 · 2025-12-31Filed 2026-07-14
| Metric | Value |
|---|---|
| Revenue | €31.6K |
| Net income | €1.4K |
| Operating income | €1.8K |
| Total assets | €38K |
| Total liabilities | €32.4K |
| Total equity | €5.7K |
| Net margin | 4.4% |
| Return on equity | 24.4% |
| Return on assets | 3.6% |
| Debt to equity | 5.69× |
Free, no sign-up — built from official regulator filings.
Source: INPI, Registre national des entreprises (comptes annuels) — Licence de réutilisation des informations du RNE, homologuée